ABCL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abcellera Biologics Inc

Watchlist Manager

Watchlist

Price: 5.73 USD

Market Cap: $1.7B

	Abcellera Biologics Inc NASDAQ:ABCL	CA
	Keppel Corporation Ltd OTC:KPELY	SG
C	Carabao Group PCL SET:CBG	TH
C	Cascadia Minerals Ltd XTSX:CAM	US
M	Man Wah Holdings Ltd SWB:AAM	HK
	Sunstone Hotel Investors Inc NYSE:SHO	US
B	Buckle Inc F:BK2	US
U	UOB-Kay Hian Holdings Ltd F:4LJ	SG
	Dundee Sustainable Technologies Inc OTC:DNDDF	CA
O	Orezone Gold Corp TSX:ORE	CA
C	CNOOC Ltd XMUN:NC2B	CN
	Hawaiian Electric Industries Inc NYSE:HE	US
	Tuya Inc F:7850	CN

Profitability Summary

Abcellera Biologics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-289%

Negative 3Y Average Operating Margin

-715%

Declining Operating Margin

-80% > -289%

Negative Net Margin

-195%

Negative 3Y Average Net Margin

-416%

Declining Net Margin

-51% > -195%

Negative Free Cash Flow Margin

-232%

Negative 3Y Average Free Cash Flow Margin

-401%

Declining Free Cash Flow Margin

-130% > -232%

Negative ROE

-14%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-30%

Declining ROIC

-19% > -24%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.